ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 158

Musculoskeletal Ultrasound Is a Sensitive Imaging Tool for the Assessment of Dynamic Changes of Bone Erosions in Inflammatory Arthritis: A Comparative Analysis with High-Resolution Peripheral Quantitatve Computed Tomography

Stephanie Finzel1,2, Marina Backhaus3, Sebastian Kraus4, Georg Schett5 and Reinhard Voll6, 1Department of Rheumatology and Clinical Immunology, Medical Faculty, University Medical Center, University of Freiburg, Freiburg, Germany, 2Department of Internal Medicine III, Rheumatology and Immunology, University of Erlangen, 91054, Germany, 3Rheumatology, Park-Klinik Weissensee, Berlin, Germany, 4Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 5Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 6Dpt. Rheumatology & Clinical Immunology and Centre for Chronic Immunodeficiency, University Hospital Freiburg, University Medical Center, University of Freiburg, Freiburg, Germany

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: HR-pQCT, imaging techniques, Psoriatic arthritis, rheumatoid arthritis (RA) and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Imaging of Rheumatic Diseases - Poster I: Ultrasound and Emerging Technologies

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Correct detection of bone erosions is crucial both for diagnosis and for monitoring of treatment response in patients with inflammatory joint diseases. Musculoskeletal ultrasound (MSUS) is known to have a higher sensitivity than conventional radiography regarding detection of bone erosions (1). Therefore, MSUS is increasingly used as an imaging outcome parameter. Standardization and validation of MSUS is a current task of the OMERACT ultrasound working group. Aim: Our study aimed to investigate the sensitivity and specificity of MSUS in the detection of erosions over time compared to HR-pQCT as a gold standard.

Methods: This is a follow-up study on our 2012 cross-sectional comparative analysis on MSUS and HR-pQCT (2). Four of 6 healthy individuals, 6/6 psoriatic arthritis patients and of 9/14 rheumatoid arthritis patients were available for follow-up and received an MSUS and an HR-pQCT scan of the clinically dominant hand. Again, bone erosions at the radial, palmar, and dorsal site of metacarpophalangeal (MCP) joint two, as well as the palmar and dorsal regions MCP joints 3 and 4 were assessed for prevalence and severity. Data were then compared to those taken in 2012. Prevalence and severity of bone erosions as determined by US and by micro-CT were recorded and compared. MSUS was graded as described earlier (2).

Results: After eliminating those datasets without follow-up from the baseline cohort sensitivity of MSUS as compared to HR-pQCT for correct detection of erosions was 95% and specifiity was 74%. For this analysis, grade 1 lesions were included. At follow-up sensitivity was 85% and specifiity 79%. At follow-up, 36 MSUS-lesions were no longer detectable in MSUS; 21/36 were false-positive lesions at baseline. Only one false-positive lesions was detected at both time points. One new lesion was detected by MSUS and confirmed by HR-pQCT. Overall grading in MSUS indicating severity of one erosions regressed; these findings were confirmed by HR-pQCT (p=0.04).

Conclusion: This is the first study assessing change of bone erosions over time using MSUS and HR-pQCT. MSUS was confirmed a sensitive imaging tool able to detect dynamic changes of erosions; it could be used for monitoring of treatment response in inflammatory joint diseases. Knowledge of predilection sites of erosions and physiological cortical breaks might help to correctly differentiate bone erosions from vessel channels and further increases the diagnostic value of MSUS. References: 1. Wakefield RJ, Gibbon WW, Conaghan PG, O’Connor P, McGonagle D, Pease C, et al. The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum. 2000 Dec;43(12):2762-70. 2. Finzel S, Ohrndorf S, Englbrecht M, Stach C, Messerschmidt J, Schett G, et al. A detailed comparative study of high-resolution ultrasound and micro-computed tomography for detection of arthritic bone erosions. Arthritis Rheum.  May;63(5):1231-6.


Disclosure: S. Finzel, None; M. Backhaus, None; S. Kraus, None; G. Schett, None; R. Voll, None.

To cite this abstract in AMA style:

Finzel S, Backhaus M, Kraus S, Schett G, Voll R. Musculoskeletal Ultrasound Is a Sensitive Imaging Tool for the Assessment of Dynamic Changes of Bone Erosions in Inflammatory Arthritis: A Comparative Analysis with High-Resolution Peripheral Quantitatve Computed Tomography [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/musculoskeletal-ultrasound-is-a-sensitive-imaging-tool-for-the-assessment-of-dynamic-changes-of-bone-erosions-in-inflammatory-arthritis-a-comparative-analysis-with-high-resolution-peripheral-quantita/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/musculoskeletal-ultrasound-is-a-sensitive-imaging-tool-for-the-assessment-of-dynamic-changes-of-bone-erosions-in-inflammatory-arthritis-a-comparative-analysis-with-high-resolution-peripheral-quantita/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology